Sigma Healthcare (SIG) Stock Overview
Operates as a retail pharmacy franchisor and pharmaceutical wholesale and distributor to community pharmacies primarily in Australia. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
SIG Community Fair Values
Create NarrativeSee what 35 others think this stock is worth. Follow their fair value or set your own to get alerts.
Sigma Healthcare Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$2.64 |
| 52 Week High | AU$3.27 |
| 52 Week Low | AU$2.58 |
| Beta | 0.34 |
| 1 Month Change | -7.69% |
| 3 Month Change | 0% |
| 1 Year Change | -18.77% |
| 3 Year Change | 210.59% |
| 5 Year Change | 340.00% |
| Change since IPO | -9.90% |
Recent News & Updates
Calculating The Fair Value Of Sigma Healthcare Limited (ASX:SIG)
Key Insights The projected fair value for Sigma Healthcare is AU$3.12 based on 2 Stage Free Cash Flow to Equity Sigma...With Sigma Healthcare Limited (ASX:SIG) It Looks Like You'll Get What You Pay For
Sigma Healthcare Limited's ( ASX:SIG ) price-to-earnings (or "P/E") ratio of 62.9x might make it look like a strong...Recent updates
Shareholder Returns
| SIG | AU Healthcare | AU Market | |
|---|---|---|---|
| 7D | -9.6% | -4.3% | 1.7% |
| 1Y | -18.8% | -17.6% | 2.2% |
Return vs Industry: SIG underperformed the Australian Healthcare industry which returned -17.6% over the past year.
Return vs Market: SIG underperformed the Australian Market which returned 2.2% over the past year.
Price Volatility
| SIG volatility | |
|---|---|
| SIG Average Weekly Movement | 3.7% |
| Healthcare Industry Average Movement | 6.1% |
| Market Average Movement | 10.1% |
| 10% most volatile stocks in AU Market | 17.2% |
| 10% least volatile stocks in AU Market | 4.0% |
Stable Share Price: SIG has not had significant price volatility in the past 3 months compared to the Australian market.
Volatility Over Time: SIG's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1912 | n/a | Vikesh Ramsunder | sigmahealthcare.com.au |
Sigma Healthcare Limited operates as a retail pharmacy franchisor and pharmaceutical wholesale and distributor to community pharmacies primarily in Australia. It offers support services to a network of franchised retail pharmacies; third and fourth party logistics services to pharmaceutical manufacturers and other supplier partners; and health services. The company operates stores under the Chemist Warehouse, Amcal, and Discount Drug stores brand names.
Sigma Healthcare Limited Fundamentals Summary
| SIG fundamental statistics | |
|---|---|
| Market cap | AU$30.37b |
| Earnings (TTM) | AU$599.81m |
| Revenue (TTM) | AU$9.55b |
Is SIG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SIG income statement (TTM) | |
|---|---|
| Revenue | AU$9.55b |
| Cost of Revenue | AU$7.78b |
| Gross Profit | AU$1.77b |
| Other Expenses | AU$1.17b |
| Earnings | AU$599.81m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.052 |
| Gross Margin | 18.55% |
| Net Profit Margin | 6.28% |
| Debt/Equity Ratio | 16.3% |
How did SIG perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/13 20:37 |
| End of Day Share Price | 2026/06/12 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Sigma Healthcare Limited is covered by 16 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Thomas Kierath | Barrenjoey Markets Pty Limited |
| John Hester | Bell Potter |
| Lyanne Harrison | BofA Global Research |